Thus, although the use of an external magnetic field inhibited the infiltration of relayed tumor-specific CD8+ T cells at the tumor site, it promoted their retention in tumor-targeting lymph nodes, which in turn improved the targeting of APS-MNPs-modified tumor-specific T cells and was effective in preventing tumor recurrence and metastasis. This evidence concerns the gene CD8A and neoplasm.